A traditional Chinese medicine formula extracts stimulate proliferation and inhibit mineralization of human mesenchymal stem cells in vitro

作者：Chen, Muwan; Feng, Wenzhou; Cao, Hui; Zou, Lijin; Chen, Chungui; Baatrup, Anette; Nielsen, Anne Bay; Li, Haisheng; Kassem, Moustapha; Zou, Xuenong^*; Bunger, Cody

来源：Journal of Ethnopharmacology, 2009, 125(1): 75-82.

DOI：10.1016/j.jep.2009.06.013

• TCM extracts
• Human mesenchymal stem cell
• Cell proliferation
• Osteogenic differentiation
• Osteoarthritis

Aim of the study: To investigate the effects of a traditional Chinese medicine (TCM) formula extract, named as ZD-I, on the proliferation and osteogenic differentiation of human mesenchymal stem cells (hMSCs) in vitro.
Materials and methods: When hMSCs cultivated in the basal medium with ZD-I, cell viability was assessed by MTT assay and cellular proliferation was assessed by SYBR green I assay. The effects of ZD-I on osteogenic differentiation of hMSCs were assessed by alkaline phosphatase (ALP) activity, mineralization assay and real-time RT-PCR.
Results: ZD-I (0.78-100 mu g/ml) was non-cytotoxic. The 50% inhibitory concentration (IC50) of hMSCs was 200 mu g/ml. ZD-I (0.78-50 mu g/ml) stimulated the proliferation of hMSCs. ZD-I did not change ALP activity of hMSCs cultivated in osteogenic medium in the early stage (4 and 7 days), but ZD-I inhibited the mineralization of hMSCs through down-regulation of several osteogenic markers (e.g. osteocalcin, bone morphogenetic protein 2 and osteopontin) in the late stage.
Conclusions: ZD-I stimulate cellular proliferation and decrease the bone mineral deposition of hMSCs. These results suggest ZD-I may play an important therapeutic role in osteoarthritic patients by improving proliferative capacity of hMSCs and inhibiting the mineralization of hMSCs.

• 出版日期2009-8-17
• 单位中山大学